Ontario Myocarditis Data and Pfizer Vaccine Trial Deaths

These represent increases of 87% and 76%.

And so a lot of the talking points that we've heard have been that

myocarditis is rare and transient.

Um, I would probably argue that the data for 16 million

people in Ontario

would say

something other than that.

I'd just like to go through, uh... This is just a

timeline of the data that came out at various time points for

myocarditis. So this was one of the, the side effects that

was attributed to the

vaccine.

So on the far left-hand side, you can see that, uh, that's kinda

time zero, and that's whenever the, the mRNA product was

rolled out, and it was ba- it was rolled out based on level one

evidence, which is

a randomized controlled trial, uh, but only two months of level one

evidence. It was a fairly large study,

but it's very difficult to understand

within two months if something could be harmful to the heart or not,

uh, a little bit longer. So each of those bands afterwards

are six-month

intervals. So a little further along, you get the six-month follow-up data

for the randomized controlled trial, specifically for Pfizer.

And in that trial,

which came out, you know, in September

2021, you have this, if you actually looked

and analyzed the deaths,

you have nine cardiovascular deaths in the mRNA product arm

and five cardiovascular deaths in the placebo arm